Categories List
Payment Methods
Shipping Option






Shopping cart
People who bought this, also bought:
Grisactin is an antifungal medication which is used to treat fungal infections of the skin, hair, and nails.
$0.57
Buy now
Nizoral is an antifungal antibiotic which is used to treat candidiasis, blastomycosis, coccidioidomycosis, histoplasmosis, chromoblastomycosis, or paracoccidioidomycosis.
$1.73
Buy now
Sporanox is an azole antifungal medicine used used to treat blastomycosis, histoplasmosis and aspergillosis.
$4.38
Buy now
Phenergan is treating different types of allergy symptoms, including itching, runny nose, sneezing, itchy or watery eyes, hives, and itchy skin rashes.
$0.53
Buy now
Grifulvin V is an antifungal medication which used to treat fungal infections of the skin, scalp, and nails.
$0.82
Buy now
Diflucan is anti-fungal antibiotic used against candidiasis of different organs including genital area.
$0.88
Buy now
Testimonials
Charles from Paris
Dudes, this service is good! It is my third order. This time it is Smok-ox and I have almost quit smoking. I know how they order system works and when my package is a bit late I do not worry because I ... Edmond from UK
If there would not be on-line sale of generics I would have to waste so much money on expensive drugs. Quality is good and it works the way as described. I want to thank guys who started all this. I will ...
Social bookmarks
News
Three million child deaths linked to drug resistance, study shows
Children in Africa and South East Asia are most at risk from antibiotics medicines no longer working, a study suggests. Lab-grown human teeth to 'fill in the gaps' in regenerative dentistry
Scientists from King's College London manage to grow a human tooth under laboratory conditions. Cancer pill gave me 'four years of extra time'
More than 1,000 women a year with advanced cancer could benefit from capivasertib which can slow the disease. Saliva test may turn tide on prostate cancer, claim scientists
Analysing DNA in saliva can identify men at the greatest risk of prostate cancer